EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Autoantibodies and T Cells Target Citrullinated and Homocitrullinated Antigens in Rheumatoid Arthritis

Eddie A James iD, Aisha Callebaut iD, Jane H Buckner iD, William W Kwok iD

Immunological Reviews · 2026

DOI: 10.1111/imr.70178 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunological Reviews, 2026. Verfasst von Eddie A James und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Immunology, Benaroya Research Institute, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, T-Lymphocytes, Citrulline, Autoantibodies. Die Arbeit nennt 133 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatoid Arthritis (RA) is a prevalent form of inflammatory arthritis in which post‐translational modifications are known to play a major role in the loss of tolerance. This review summarizes current knowledge of the role that such modifications play in the disease. Most individuals with RA have antibody responses directed against citrullinated and/or carbamylated self‐antigens, but additional modifications are under active investigation. Post‐translational modifications can alter the primary protein sequence, increasing binding to HLA molecules and recognition by T cells, and can generate new epitopes that are recognized by autoantibodies. They can also perturb protein structure and alter protein processing, enhancing presentation of cryptic epitopes. Finally, these modifications can alter protein function, potentially undermining cellular identity and function. Potentiation of post‐translational modifications has been directly linked to environmental exposures that are epidemiologically tied to RA risk. The immunogenic effects of protein modification are associated with key variants that confer genetic risk for RA. Notably, immune assays designed to measure antibody recognition and monitor T cell responses directed against citrullinated and carbamylated antigens have emerged as useful biomarkers of disease risk and activity. The pathways of protein citrullination and carbamylation are also important targets for potential preventative and curative therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidT-LymphocytesCitrullineAutoantibodiesAutoantigensHumansProtein Processing, Post-TranslationalAnimalsCitrullinationProtein Carbamylation

Substanzen

CitrullineAutoantibodiesAutoantigenshomocitrulline

Autor:innen und Institutionen

  • Center for Translational Immunology, Benaroya Research Institute, Seattle, Washington, USA.

ORCID-Profile: Eddie A James, Aisha Callebaut, Jane H Buckner, William W Kwok

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

James, E. A., Callebaut, A., Buckner, J. H., & Kwok, W. W. (2026). Autoantibodies and T Cells Target Citrullinated and Homocitrullinated Antigens in Rheumatoid Arthritis. Immunological Reviews. https://doi.org/10.1111/imr.70178

Vancouver

James EA, Callebaut A, Buckner JH, Kwok WW. Autoantibodies and T Cells Target Citrullinated and Homocitrullinated Antigens in Rheumatoid Arthritis. Immunological Reviews. 2026. doi:10.1111/imr.70178

BibTeX
@article{James2026,
  author = {James, Eddie A and Callebaut, Aisha and Buckner, Jane H and Kwok, William W},
  title = {Autoantibodies and T Cells Target Citrullinated and Homocitrullinated Antigens in Rheumatoid Arthritis},
  journal = {Immunological Reviews},
  year = {2026},
  doi = {10.1111/imr.70178}
}
Kostenlos starten →